ABSTRACT
Adolescent e-cigarette use (also known as vaping), globally and within Australia, has steadily increased in recent years, with e-cigarettes now the most heavily used nicotine-containing products amongst adolescents. In response to the rise in prevalence, governments have introduced legislation to curb the supply of e-cigarettes to adolescents. To supplement these legislation measures, leading (inter)national public health agencies have called for the development of education and communication programs aimed at reducing adolescent e-cigarette uptake. Text-message programs for adolescents represent a potentially potent approach to achieve this. In this study, we assessed the acceptability of text-messages sent to adolescents and their parents to target factors associated with e-cigarette use. Text-messages were found to be acceptable to both adolescents and their parents however the effectiveness of the program on adolescent e-cigarette use still needs to be established prior to broader scale-up and investment.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ACTRN12623000079640
Funding Statement
This research is supported by a Hunter Medical Research Institute (HMRI) Early Career Project Grant and University of Newcastle School of Medicine and Public Health Project Grant and the NHMRC Centre for Research Excellence (No. APP1153479) - the National Centre of Implementation Science. Courtney Barnes receives salary support from a NSW Ministry of Health PRSP Research Fellowship. Luke Wolfenden receives salary support from an NHMRC Investigator (L1) Fellowship (APP11960419) and NSW Cardiovascular Research Capacity Program grant number H20/28248. The funders have played no role in the conduct of the trial. Hunter New England Local Health District, Population Health and the University of Newcastle provided infrastructure and in-kind funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of University of Newcastle gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.